Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

MLA

Daniël H. van Raalte, et al. “Antihypertensive Effects of SGLT2 Inhibitors in Type 2 Diabetes.” The Lancet Diabetes & Endocrinology, vol. 4, Mar. 2016, pp. 188–89. EBSCOhost, https://doi.org/10.1016/s2213-8587(15)00457-x.

APA

Daniël H. van Raalte, Marcel H. A. Muskiet, & Erik J.M. van Bommel. (2016). Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes. The Lancet Diabetes & Endocrinology, 4, 188–189. https://doi.org/10.1016/s2213-8587(15)00457-x

Chicago

Daniël H. van Raalte, Marcel H. A. Muskiet, and Erik J.M. van Bommel. 2016. “Antihypertensive Effects of SGLT2 Inhibitors in Type 2 Diabetes.” The Lancet Diabetes & Endocrinology 4 (March): 188–89. doi:10.1016/s2213-8587(15)00457-x.